Canadian Organization for Rare Disorders
254 SlideShares 54 Followers
Personal Information
Organization / Workplace
Toronto, Ontario Canada
Industry
Medical / Health Care / Pharmaceuticals
Website
www.raredisorders.ca
About
CORD is Canada's national network for organizations representing all those with rare disorders. CORD provides a strong common voice to advocate for health policy and a healthcare system that works for those with rare disorders. CORD works with governments, researchers, clinicians and industry to promote research, diagnosis, treatment and services for all rare disorders in Canada.
Contact Details
  • Documents
  • Infographics
Latest Most Popular

Refocus PMPRB “Back to the Future”: Part One.

2 years ago • 322 Views

Summer Webinar 2: Engaging Political Parties, Politicians, and Policy Makers on Patient Needs

2 years ago • 172 Views

Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election

2 years ago • 233 Views

Webinar 3: Bringing Home the 5% Solution

2 years ago • 188 Views

Webinar 2: Matching Access to Risk (Toon Digneffe slides)

2 years ago • 136 Views

Rare Disease Day Conference: From Draft to Action Plan

3 years ago • 274 Views

Webinar 9: Everything you Need to Know to Respond to Canada’s Discussion Guide to “Building a National Strategy for High-Cost Drugs for Rare Diseases”

3 years ago • 242 Views

Webinar 8: Laying A Factual Foundation for Canada’s Rare Drug Program

3 years ago • 196 Views

Webinar 7: How Other Countries Provide Access to Rare Disease Drugs

3 years ago • 282 Views

Crowdsourcing Key Issues on Pan-Canadian Rare Drug Program

3 years ago • 159 Views

Re-imaging Canada’s Rare Drug Strategy (Webinar 4)

3 years ago • 221 Views

PMPRB: Friend or Foe of Rare Disease Drug Strategy

3 years ago • 186 Views

Preventive and risk-reduction therapies: examples from rare blood disorders

3 years ago • 299 Views

Does Canada need an Orphan Drug Policy to incentivize drug development and submissions? (Webinar 1:)

3 years ago • 247 Views

July 30 Webinar 3: Sharing and comparing feedback for the PMPRB Guidelines

3 years ago • 298 Views

July 16 Webinar 2: What we heard and what we didn’t hear at the PMPRB Public Forum

3 years ago • 407 Views

July 6 Webinar: (How) Will Canadians Access Once-in-a- Lifetime Gene Therapy?

3 years ago • 247 Views

Webinar 1: Has the PMPRB removed the obstacles to access in its Guidelines?

3 years ago • 521 Views

Webinar 3: Alternative Approaches to Innovative Drug Pricing

4 years ago • 451 Views

Webinar 2: Drug Launches: What Influences the Decision to Deploy New Medicines?

4 years ago • 353 Views